Abstract:Abstract Introduction: Next-generation sequencing (NGS) has become a critical tool for both biological research and in-vitro diagnostics, though there remains a need for new DNA sequencing platforms that combine high accuracy, speed, and flexible throughput to provide timely results and cost-effective operations. Here we evaluate the utility of the novel Singular Genomics G4 sequencing platform for cancer research applications by performing whole exome sequencing (WGS) of the human reference control HG001. We further demonstrate performance for methyl-seq, bulk RNA-seq, and scRNA-seq. Methods: To assess performance, we prepared a human whole exome library (IDT xGen Exome) from HG001 gDNA, then sequenced the library via the G4 sequencing platform with F2 flowcells (150M read throughput) to yield 483M 2x150bp reads. Sequence quality and mapping metrics were obtained via GATK4 after read alignment to Grch38 via bwa mem. Germline variants were identified via DeepVariant v1.4 using the Illumina WES model, implemented via Parabricks; performance was assessed by hap.py. Methyl-seq performance was examined by methylDackel analysis of an EM-Seq library (NEB) prepared from 50ng HG001 gDNA and sequencing to 20x coverage via 2x150bp reads. Bulk RNA-seq performance was assessed by replicate sequencing of UHR total RNA on the G4 and Illumina NextSeq platforms. Single cell RNA-seq libraries were prepared from healthy donor PBMC via the 10x Chromium, sequenced on the G4 and Illumina NovaSeq, then analyzed via Cell Ranger, Scanpy and scvi-tools. Results: Exome sequencing of HG001 yielded high quality data (single pass accuracy > 99.7% for R1 and R2) with even coverage of the genome (fold 80 =1.42). hap.py analysis of DeepVariant calls yielded a SNP and Indel F1 of 99.06 and 96.05%, respectively, over high confidence regions. Performance was high over challenging features such as low complexity DNA and GC rich regions. EM-Seq analysis revealed global distributions of cytosine methylation that closely matched public EM-Seq data derived from the Illumina NovaSeq. Bulk RNA-seq transcript counts were highly correlated across technical replicates (R2 = .990) and platforms (R2= .988). Pseudo-bulk analysis of scRNA-seq libraries showed high cross-platform correlation (R2= .982), with nearly identical CellTypist annotations (Adjusted Rand Index = .999). Conclusions: The G4 sequencer delivers sequencing data on par with the state-of-the-art in NGS, but with a faster turnaround than traditional SBS systems. Notably, we observe a high concordance with the leading NGS platform for human DNA variant detection, methyl-seq, bulk RNA-seq and scRNA-Seq. We anticipate the rapid turnaround and flexible throughput of the G4 will have broad utility for basic and translational cancer research applications. Citation Format: Kenneth Gouin, Liz LaMarca, Yu Xiang, Anne Decker, Sabrina Shore, Ryan Shultzaberger, Daan Witters, Timothy Looney, Martin M. Fabani, Eli Glezer. Performance assessment of the novel G4 sequencing platform for cancer research applications [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 220.

Comparative performance of the BGI and Illumina sequencing technology for single-cell RNA-sequencing

Comparative Performance of the BGISEQ-500 and Illumina HiSeq4000 Sequencing Platforms for Transcriptome Analysis in Plants

Comparative Analysis of Sequencing Technologies for Single-Cell Transcriptomics

Illumina SBS Sequencing and DNBSEQ Perform Similarly for Single-Cell Transcriptomics

Comparative Analysis of NovaSeq 6000 and MGISEQ 2000 Single-Cell RNA Sequencing Data.

Comparative Analysis of Commercial Single-Cell RNA Sequencing Technologies

A comprehensive analysis framework for evaluating commercial single-cell RNA sequencing technologies

The Comparison of Two Single-cell Sequencing Platforms: BD Rhapsody and 10x Genomics Chromium

Evaluation of the MGISEQ-2000 Sequencing Platform for Illumina Target Capture Sequencing Libraries

Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing

Direct Comparative Analyses of 10X Genomics Chromium and Smart-seq2

Systematic evaluation of single-cell RNA-seq analyses performance based on long-read sequencing platforms

Cross-platform Comparisons for Targeted Bisulfite Sequencing of MGISEQ-2000 and NovaSeq6000

Performance comparison of high throughput single-cell RNA-Seq platforms in complex tissues

Cross-platform comparisons for DNA methylation sequencing

Systematic comparative analysis of single cell RNA-sequencing methods

The comparison of single-cell RNA sequencing platforms based droplets

Advanced sequencing-based high-throughput and long-read single-cell transcriptome analysis

Comparative Analysis of Single-Cell RNA Sequencing Methods with and without Sample Multiplexing

Advanced sequencing-based high-throughput and long-read single-cell transcriptome analysis.

Abstract 220: Performance assessment of the novel G4 sequencing platform for cancer research applications